ctrl K

Xilio Therapeutics Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.75

-0.01 (-0.66%)

At close: May 02, 2025, 3:59 PM

0.76

1.33%

After-hours: May 02, 2025, 05:03 PM EDT

Xilio Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
PE Ratio	-0.88	-0.2	-0.84	-5.89	-7.96	-25.39K
PEG Ratio	0.01	0.02	-0.05	-0.17	-0.00	n/a
PS Ratio	8.06	n/a	n/a	n/a	n/a	n/a
PB Ratio	2.90	0.41	0.70	2.36	-5.28	-14.89K
P/FCF Ratio	-2.78	-218.83	-0.95	-5.35	-11.48	-23.68K
P/OCF Ratio	-2.78	-0.22	-0.97	-5.42	-12.18	-24.63K
OCF/S Ratio	-2.9	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.46	0.31	0.19	0.11	-0.25	-0.63
Quick Ratio	2.21	3.02	5.89	15.85	0.93	9.81
Current Ratio	2.21	3.02	5.89	15.85	0.93	9.81
Asset Turnover	0.09	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	-125.07	-90.94	n/a
Return on Equity	-3.31	-2.07	-0.83	-0.4	0.66	0.59
Return on Assets	-0.82	-1.25	-0.63	-0.34	-1.52	-0.28
Return on Invested Capital	-1.35	-1.64	-0.7	-0.36	-3.25	-0.33
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	0.74	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	-9.18	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	-9.18	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	-9.55	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	-8.91	n/a	n/a	n/a	n/a	n/a